Company / Revenue
KYNTRA BIO, INC. Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$29.6M
FY2025
5-year range
$29.6M / $256.6M
FY2021-FY2025
Trend
-36.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue has fluctuated over the past 10 years, ranging from $30M in FY2025 to $257M in FY2021.
Based on SEC 10-K filings.
$30M in FY2025 with a 5-year CAGR of -32.6%.
Declined from $235M to $30M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- -44.8%
- 5-Year CAGR
- -32.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -32.6%, indicating a declining trend.
- In FY2025, revenue decreased 36.7% year-over-year.
- Peak revenue was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -3.33 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $29.6M | -36.7% |
| FY2024 | $46.8M | -80.1% |
| FY2023 | $235.3M | +33.5% |
| FY2022 | $176.3M | -31.3% |
| FY2021 | $256.6M | +20.5% |
| FY2020 | $213.0M | +62.6% |
| FY2019 | $131.0M | -28.5% |
| FY2018 | $183.2M | +1.3% |
| FY2017 | $180.8M | +31.4% |
| FY2016 | $137.6M | +34.7% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026